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Abstract  
Objective: To investigate changes in tobacco smoking in two consecutive pregnancies and factors 
associated with the change. 
Design: Population-based cohort study. 
Setting: New South Wales, Australia, 2000-2010 
Population: 183,385 women having first and second singleton pregnancies. 
Methods: Descriptive and multivariable logistic regression analyses of perinatal data linked to 
hospital admission data. 
Main outcome measures: Proportion of women smoking during their first pregnancy who quit by 
their second, and of women not smoking in their first pregnancy who did smoke during their 
second. 
Results: Among 22,761 smokers in the first pregnancy, 33.5% had quit by their second. Among 
160,624 non-smokers in their first pregnancy, 3.6% smoked during their second. Women who aged 
≥25 years, were married, born in a non-English speaking country, used private obstetric care, and 
lived in a socio-economically advantaged area were more likely to quit or less likely to start 
smoking in the second pregnancy. Smokers who had gestational hypertension (adjusted odds ratio 
and 95% confidence interval: 1.36, 1.23-1.51), a large-for-gestational-age infant (1.66, 1.46-1.89), 
and a stillbirth (1.44, 1.06-1.94) were more likely to quit, whereas smokers whose infant was small-
for-gestational-age (0.65, 0.60-0.70) or admitted to special care nursery (0.87, 0.81-0.94) were less 
likely to quit. Among non-smokers in the first pregnancy, the risk of smoking in second pregnancy 
increased with late antenatal attendance (e.g. ≥26 weeks, 1.30, 1.14-1.48), gestational diabetes 
(1.25, 95%CI 1.07-1.45), preterm birth (e.g. spontaneous 1.25, 1.10-1.43), caesarean section (e.g. 
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prelabour 1.13, 1.01-1.26), and infant small-for-gestational-age (1.37, 1.26-1.48) or required special 
care nursery (1.14, 1.06-1.23). Inter-pregnancy interval of ≥3 years was associated with either 
change in smoking status. 
Conclusions: Most smokers continue to smoke in their next pregnancy, even among those who 
experienced poor outcomes. Intensive interventions should be explored and offered to women at the 
highest risk. 
Keywords: epidemiology, smoking, quitting, pregnancy outcomes 
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INTRODUCTION 
 
The prevalence of tobacco smoking during pregnancy remains high in high-income western 
countries (11%-17%),
1-5
 despite a decline over the past two decades.
1,3,6
 Smoking during pregnancy 
is one of the most potentially preventable causes of a range of adverse pregnancy outcomes, 
including placental abruption, miscarriage, fetal growth restriction, preterm births, and perinatal 
deaths.
6-9
 Quitting smoking reduces the risk of preterm births and low birthweight by 20%.
9
 
However, in western countries, less than half of women (4%-47%) quit spontaneously when they 
become pregnant.
10
 A majority of smoking women (69%-75%) continue to smoke in their 
subsequent pregnancies.
4,8,11-13
 Existing studies from the United States (US),
11,12
 Sweden
4
 and 
Norway
13
 report that maternal socio-demographic circumstances and psychological distress play an 
important role in maternal smoking in subsequent pregnancies. However, there is a paucity of 
evidence on whether experience of an adverse pregnancy outcome in an index pregnancy influences 
maternal smoking status during the next pregnancy.
4,11
 
 
Australia is a world-leader in tobacco control policies.
14
 Public health measures, including increased 
taxation, smoke-free environment legislation, expanded graphic health warnings, restricted tobacco 
advertising, and plain packaging and display have reduced the smoking rate in the general 
population.
14
 There are concerted efforts among health professionals across disciplines to promote 
smoking cessation in pregnancy.
7,15,16
 Clinical practice guidelines to assist health professionals in 
identifying pregnant women who smoke and providing them with interventions and support to quit 
have been developed and disseminated broadly.
7,15,16
 As a result, increasing levels of advice and 
support for smoking cessation have been offered to pregnant smoking women.
17,18
 In addition, in 
Australia, eligible smokers are provided access to subsided smoking cessation medications 
including nicotine replacement therapy, varenicline and bupropion.
15
 Currently an evaluation of the 
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utilisation, effectiveness and safety of smoking pharmacotherapies among Australian pregnant 
women is underway.
19
 
 
Within Australia’s context of well-developed tobacco control policies and publicly funded health 
system, the extent to which women change their smoking status between pregnancies and—
importantly—factors that influence this behavioral change, are unknown. Identifying these 
determinants can inform strategies and interventions to better target women at high risk of smoking 
during pregnancy. This study investigated the extent to which women who smoked during their first 
pregnancy quit by their second, and women who did not smoke in their first pregnancy did smoke 
during their second, and how the change in smoking status varied according to first pregnancy 
factors, including maternal socio-demographic characteristics, medical conditions, antenatal 
attendance, and pregnancy outcomes. 
 
METHODS 
 
Data sources and linkage 
The study cohort included 183,385 women in New South Wales (NSW), Australia, who had first 
and second singleton pregnancies between July 2000 and December 2010. NSW is Australia’s most 
populous state with 7.2 million residents as of June 2011
20
 and 93,000 births per annum delivered in 
more than 100 hospitals.
21
 The study used perinatal records extracted from the NSW Perinatal Data 
Collection (referred to as “perinatal record”) and maternal hospital admission records (for a 
delivery) extracted from the NSW Admitted Patient Data Collection (referred to as “hospital 
admission record”). Perinatal records were linked to hospital admission records to create a set of 
longitudinal and enriched data about the cohort’s consecutive pregnancies. 
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The Perinatal Data Collection is a legislated and population-based surveillance system covering all 
births (live births and stillbirths of at least 20 weeks gestation or at least 400 grams birth weight) in 
NSW public and private hospitals, and at home.  The perinatal data collect information on the health 
of mothers and babies, including maternal socio-demographic characteristics, smoking status, pre-
existing and gestational diabetes and hypertension, and outcomes of the pregnancy.
21
 
 
The Admitted Patient Data Collection is a mandatory data collection of all hospital discharges from 
all public, private and repatriation hospitals, and private day procedure centres in NSW. The data 
contain maternal socio-demographic characteristics, diagnoses, and procedures undertaken. For 
each hospital admission record, between one and 55 diagnoses are coded according to the 
International Statistical Classification of Diseases and Related Health Problems, Tenth Revision, 
Australian Modification (ICD-10-AM).
22
 
 
Records from the two sources of data were linked by the NSW Centre for Health Record Linkage. 
As Australia does not have a unique registration number for citizens, the linkage process used a 
probabilistic matching method
23,24
 and the privacy preserving approach.
25
 The validity of the 
probabilistic record linkage is extremely high, with less than 0.3% false positive links, and less than 
0.5% missed links.
23,24
 Only de-identified data were provided to researchers. 
 
Study outcomes and variables 
The primary outcome of the study was the proportion of women who smoked during their first 
pregnancy and quit by their second pregnancy, and conversely, the proportion of women who did 
not smoke in the first pregnancy but smoked during their second pregnancy. 
 
The perinatal data included a check box (‘Yes’, ‘ No’) for the item ‘Did the mother smoke 
cigarettes at all during pregnancy?’.21 In hospital admission data, the assignment of the Z72.0 
6 
diagnostic code in any diagnosis field indicates the use of tobacco in the last month.
22
 For this 
study, a woman was identified as a smoker if this was indicated in the perinatal record or in the 
hospital admission record. The recording of maternal smoking in perinatal records and hospital 
admission records have been validated previously (medical records as the gold standard), with 
respective sensitivities of 89.6% and 66.2%, respective positive predictive values of 96.1% and 
93.0%, and specificities of 99.0%.
26,27
 Our algorithm to combine smoking information from the two 
sources of data has similar utility to using medical records in identifying pregnant smokers.
28
 Eight 
hundred and forty-six women (0.5%) with an unknown smoking status in either the first (n=395) or 
second pregnancy (n=469) were excluded. 
 
Change in smoking status between pregnancies was examined according to socio-demographic and 
clinical characteristics. Maternal socio-demographic characteristics, including age, country of birth, 
Indigenous status, marital status, and remoteness and socio-economic status of residential areas 
were revealed from the perinatal record for the first pregnancy, whereas the use of private or public 
obstetric care was ascertained from the hospital admission record. Country of birth was grouped as 
English-speaking (Australia, New Zealand, United Kingdom and North America), Asia (South East, 
North East and Southern Asia), and other non-English speaking countries.
29
 Remoteness of 
residential area was based on the extended version of the Accessibility/Remoteness Index of 
Australia,
30
 while socio-economic status of residential area (SES) was based on quintiles of the 
Index of Relative Socio-economic Disadvantage.
31
 
 
Maternal medical conditions during the first pregnancy, including pre-existing diabetes mellitus 
(diabetes), gestational diabetes, and respiratory conditions were identified from the hospital 
admission record, whereas hypertensive disorders (pre-existing or gestational hypertension) were 
detected from perinatal record or hospital admission record. Gestational age (weeks) at the initial 
antenatal attendance (in the first pregnancy) was obtained from the perinatal record. In Australia, it 
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is recommended that the initial antenatal assessment ideally to be completed by 12 weeks of 
gestation.
32
  Inter-pregnancy interval was calculated as the number of years between the first 
infant’s date of birth and the estimated conception date of the second pregnancy. Women with inter-
pregnancy interval less than 6 months (n=27) were further excluded from analyses as they were 
likely to carry different risk profiles.
33
 
 
Outcomes of the first pregnancy derived from the perinatal record included preterm birth (<37 
weeks, medically indicated or spontaneous), mode of delivery (spontaneous vaginal, instrumental, 
prelabour and intrapartum caesarean section), stillbirth, infant birthweight (small-for-gestational-
age [SGA] <10th birth weight percentile; large-for-gestational-age [LGA] >90th percentile; and 
appropriate-for-gestational-age), Apgar score at 5 minute (<7), and baby admission to special care 
nursery or neonatal intensive care unit (referred to as “special care”). Maternal postpartum 
haemorrhage was identified from the hospital admission record. Existing evidence
26,27,34
 indicates 
high levels of agreement between medical records and perinatal records or hospital admission 
records in relation to the recording of these medical diagnoses and obstetric information. 
 
Data analysis 
Analyses were stratified by maternal smoking status during the first pregnancy. We used frequency 
distribution and contingency analyses to describe the patterns of change in smoking status from the 
first to second pregnancy. Multivariable logistic regression models were used to assess the 
association between the change in smoking status and maternal socio-demographic characteristics, 
medical conditions, antenatal attendance, and outcomes of the first pregnancy. Odds ratios (OR) and 
95% confidence intervals (CI) were adjusted for maternal age, country of birth, marital status, 
Indigenous status, private obstetric care, residential remoteness and SES, diabetes, hypertensive 
disorder, , respiratory conditions, antenatal attendance, year of first delivery, and inter-pregnancy 
interval. All analyses were carried using SAS version 9.3 (SAS Institute, Cary, NC, USA).
35
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RESULTS 
 
Maternal socio-demographic and clinical characteristics of the first pregnancy are presented in 
Table 1. Among 22,761 women who smoked during the first pregnancy, 7,632 (33.5%) had quit by 
their second pregnancy. Among 160,624 women who did not smoke in the first pregnancy, 5829 
(3.6%) did smoke in the second pregnancy. On average, smokers who had quit were 2.3 years older 
(mean age 25.6 years) than those who did not quit (mean age 23.3 years). Women not smoking in 
the first pregnancy but smoked during the second were 4.0 years younger (mean age 24.7 years) 
than those who did not smoke in either pregnancy (mean age 28.7 years). Mean inter-pregnancy 
interval was 2.7 years (standard deviation 1.5), regardless of maternal smoking status. Seventy 
seven (38.1%) smokers whose first baby was stillborn had quit by the second pregnancy (Table 1). 
 
Insert Table 1 here 
 
Results of multivariable logistic regression analyses are shown in Table 2. Over the study period 
(2000-2009), there was an increase in likelihood of pregnant smokers quitting by the second 
pregnancy. Smokers who aged ≥25years, were married, born in an Asian or another non-English 
speaking country, used private obstetric care, or who lived in a socio-economically advantaged area 
(4
th
 and 5
th
 SES quintiles) in the first pregnancy were significantly more likely to quit than other 
smokers. Women having these socio-demographic characteristics and not smoking in the first 
pregnancy were significantly less likely to start smoking in the second pregnancy than other non-
smoking women. Inter-pregnancy interval of 3 years or longer was associated with both a greater 
likelihood of quitting (OR 1.51, 95% CI 1.40-1.62) and a greater risk of starting to smoke in the 
second pregnancy (OR 1.34, 95% CI 1.25-1.43) (Table 2). 
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Smokers who had gestational hypertension  (OR 1.36, 95% CI 1.23-1.51), stillbirth (OR 1.44, 95% 
CI 1.06-1.94), or LGA infant (OR 1.66, 95% CI 1.46-1.89) were more likely to quit by their second 
pregnancy, whereas those who had the first infant born SGA (OR 0.65, 95% CI 0.60-0.70) or 
admitted to the special care (OR 0.87, 95%CI 0.81-0.94) were less likely to quit. Among women 
who did not smoke in the first pregnancy, factors associated with smoking during the second 
pregnancy included a late antenatal attendance (≥13 weeks’ gestation), gestational diabetes, preterm 
birth, caesarean section, SGA infant, or the first baby admitted to the special care nursery (Table 2). 
 
Insert Table 2 here 
 
DISCUSSION 
 
Main findings 
In this population-based prospective study, 33.5% of women who smoked during the first 
pregnancy had quit by their second pregnancy, and 3.6% of women who were not reported as 
smokers in the first pregnancy reported smoking during the second pregnancy. These changes in 
maternal smoking status between pregnancies varied, to a larger extent by maternal socio-
demographic characteristics (age, country of birth, marital status, use of private care, and residential 
area) and inter-pregnancy interval, and to a lesser extent by maternal medical conditions and 
outcomes of the first pregnancy. 
 
Strengths and limitations 
The main advantage of the current study was the use of whole-of-population data collected over a 
ten-year period. Linking perinatal data to hospital admission data allowed not only greater 
identification of pregnant smokers
28
 but also the examination of various determinants of maternal 
smoking across pregnancies. Very few studies have investigated the role of maternal medical 
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diagnoses, mode of delivery, the timing of the initial antenatal attendance, and adverse outcomes of 
the index pregnancy. As such, this study provides a greater level of evidence about the effects of 
clinical factors on maternal smoking in the subsequent pregnancy. 
 
Nevertheless, some limitations need to be considered. Maternal smoking status was primarily self-
reported. There was no information on contextual risk factors for smoking and barriers to smoking 
cessation, including household income, maternal educational attainment, social support, household 
smoking environment, and exposure to passive smoking.
1,3,6,36,37
 Additionally, it was not possible to  
investigate the role of co-existing maternal depression and mental illnesses because these conditions 
are likely to be under-reported in hospital admission data.
38
 Early pregnancy loss such as 
miscarriage and termination of pregnancy prior to 20 weeks of gestation are not included in the 
perinatal data, and amount of tobacco consumption is not consistently recorded throughout the 
pregnancy;
26
 thus these determinants could also not be examined in this study. The timing of 
changes in maternal smoking status was unknown. Finally, the generalizability of the study findings 
to other populations in settings with less developed tobacco control policies may be limited. 
 
Interpretation 
The proportion of smokers in this study who quit by the second pregnancy (33.5%) was higher than 
those being reported elsewhere (24.9%-30.9%).
4,11-13
 The proportion of women who started 
smoking during the second pregnancy (3.6%) was lower than those being reported in US studies 
(4.8%-6.2%)
11,12
 but higher than the finding from a Norweigian study (2.3%).
13
 It is an encouraging 
finding that the trend in quitting increased over the study period, which is consistent with a decline 
in prevalence of smoking in the general female population and in overall obstetric population in 
Australia during the study period.
28
 These findings are likely to reflect the effectiveness of 
Australia’s tobacco-control public health interventions,14 and efforts of health system to promote 
smoking cessation among pregnant women.
17,18
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This study found a significant role of country of birth, in which smokers born in a country other 
than Australia, New Zealand, United Kingdom, or North America were more likely to quit or never 
smoke in either pregnancies. It has been reported that Asia-born female immigrants who had longer 
duration of residence in Australia were more likely to smoke cigarettes , but compared to Australia-
born women, they were less likely to be daily or heavy smokers.
39
 Given the low female smoking 
rates in  Asia, Africa and the Middle East,
14
 it is possible that women migrating from these regions 
are likely to quit spontaneously during pregnancy, or likely to be responsive to smoking cessation 
advice. 
 
A previous study has shown that women who smoked during consecutive pregnancies have 
significantly higher risk of preterm birth and low birthweight in the later pregnancy in comparison 
to smokers who quit.
8
 It is, therefore, concerning that in this study, two thirds of women who 
smoked during the first pregnancy continued to do so during the next pregnancy despite adverse 
outcomes (stillborn, SGA, and special care admission). It would seem intuitive that women who had 
an adverse outcome might be inclined to stop smoking in order to protect the second baby. Our 
study findings reflect the highly addictive nature of tobacco smoking and strongly reinforce the 
need for appropriate interventions and support for both nulliparous women, and those who 
previously had adverse pregnancy outcomes. Counselling for smoking women who experienced 
pregnancy loss
32
, clearly, has not been completely effective to reduce smoking in these women. 
 
The implementation of the 5A’s approach protocol (Ask, Advise, Assess, Assist and Arrange for 
follow-up)
7,15,16,40
 for smoking cessation has demonstrated certain improvement in identifying 
women who smoke during pregnancy, and delivery of interventions.
17,18,41
 However, existing 
evidence
17,18,41,42
 suggests that the provision of interventions is still suboptimal. In Australia, about 
half of pregnant smokers were not given advice, written information, or referrals to smoking 
cessation services, and were not asked about smoking status in subsequent visits.
17,42
 Similarly, in 
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the US, only 42% of pregnant smokers were asked, then given advice and assistance to quit during 
the first trimester.
41
 Perinatal care is often shared among obstetricians, midwives, general 
practitioners and other health professionals in a variety of health care settings, which may interfere 
with the identification of smokers and the provision of smoking cessation interventions. Further 
strategies are needed to identify smoking women in order to implement timely intervention. 
Smoking cessation pharmacotherapies and hypnotherapy are reported as preferred methods for 
quitting by pregnant smokers.
42
 
 
Consistent with previous studies,
4,11,13
 this study found that the risk of change in maternal smoking 
increases with longer inter-pregnancy interval. Among smokers, longer inter-pregnancy interval is 
likely to reflect successful attempts to quit before the next pregnancy, but among non-smokers, it 
would indicate greater likelihood of exposure to stressors associated with smoking. It has been 
reported that socio-economically disadvantaged women often report parenting challenges, greater 
incidence of disruptive home or neighbourhood environment, and feelings of isolation and lack of 
social support, thus often view smoking as a solution to relieve their emotional issues.
36
 Both the 
immediate post-birth and pre-conception periods, certainly, should be explored as potential 
opportunities for interventions. Particular attention is needed for disadvantaged groups to ensure 
their access to smoking cessation programmes, given the strong association between socio-
demographic factors and the increased risk of smoking in the second pregnancy. 
 
It was another concerned finding that a change from non-smoking to smoking was greater among 
women who had experienced an adverse outcome (gestational diabetes, preterm birth, SGA infant, 
caesarean section, and baby requiring special care). This finding might reflect an increase in 
disclosure of smoking in the second pregnancy, rather than starting smoking among these women. 
Non-disclosure of smoking among Australian pregnant smokers is relative low (9%)
37
 compared to 
those in some other countries, such as Scotland (22%-39%),
43
 US (22.9%),
44
 and New Zealand 
13 
(25%).
45
 Women who did not disclose their smoking in the first pregnancy may be more likely to 
disclose in the second pregnancy if they perceive themselves to be at higher risk of an adverse 
outcome. The clarity of the questions being asked about smoking, encouragement from clinical 
staff, and motivations to quit are likely to contribute to voluntary self-reporting of smoking 
behaviours among pregnant women.
7,36,43
 Alternatively, women may be aware of health 
consequences of tobacco smoking during pregnancy, it is unknown whether women with the first 
infant SGA would think smoking might make the second delivery easier if the baby is small. 
 
CONCLUSION 
 
Despite harmful effects of smoking during pregnancy, two-thirds of pregnant smokers continued to 
smoke during the next pregnancy. General public tobacco-control measures and antenatal smoking 
cessation interventions are not uniformly effective for all women of child-bearing age. Further 
health system supports are needed to assist maternity care providers to identify women at risk so 
that smoking cessation advice and other interventions can be implemented before, during and 
following pregnancy. Target intervention strategies should also be explored, especially for women 
who are at higher risk of smoking. 
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Table 1: Socio-demographic and clinical characteristics of the first pregnancy according to maternal 
smoking status, n (column %) 
 
 
Smoked during first
 
 pregnancy 
 
Did not smoke in first 
pregnancy 
Quit by 
second 
pregnancy 
n (%) 
Smoked during 
second 
pregnancy 
n (%)  
Did not smoke 
in second
 
pregnancy 
n (%) 
Smoked during 
second 
pregnancy 
n (%) 
Total number 7632 (100.0) 15129 (100.0)  154795 (100.0) 154795 (100.0) 
Maternal age          
  Under 20 years 1350 (17.7) 4812 (31.8)  7365 (4.8) 1458 (25.0) 
  20-24 years 2416 (31.7) 5524 (36.5)  27099 (17.5) 1791 (30.7) 
  25-29 years 2114 (27.7) 2953 (19.5)  56193 (36.3) 1436 (24.6) 
  30-34 years 1355 (17.8) 1434 (9.5)  49205 (31.8) 881 (15.1) 
  ≥35 years 397 (5.2) 406 (2.7)  14933 (9.6) 263 (4.5) 
Country of birth 
  
  
   English speaking 6978 (91.4) 14533 (96.1)  120031 (77.5) 5126 (87.9) 
  Asian 209 (2.7) 113 (0.7)  19394 (12.5) 267 (4.6) 
  Other non-English speaking 445 (5.8) 483 (3.2)  15370 (9.9) 436 (7.5) 
Marital status        
  Never married 2910 (38.1) 8154 (53.9)  18895 (12.2) 2261 (38.8) 
  Widow, separated, others 147 (1.9) 361 (2.4)  2291 (1.5) 117 (2.0) 
  Married, de-facto 4575 (59.9) 6614 (43.7)  133609 (86.3) 3451 (59.2) 
Private/public obstetric care      
  Private 1205 (15.8) 845 (5.6)  63462 (41.0) 920 (15.8) 
  Public 6427 (84.2) 14284 (94.4)  91333 (59.0) 4909 (84.2) 
Remoteness      
  Urban area 4482 (58.7) 7233 (47.8)  111790 (72.2) 3742 (64.2) 
  Rural area 3143 (41.2) 7889 (52.1)  42850 (27.7) 2081 (35.7) 
  Unknown 7 (0.1) 7 (0.0)  155 (0.1) 6 (0.1) 
Socio-economic status      
 
1st quintile (lowest) 1375 (18.0) 3474 (23.0)  21389 (13.8) 1294 (22.2) 
 
2nd quintile 1572 (20.6) 3894 (25.7)  23209 (15.0) 1289 (22.1) 
 
3rd quintile 2038 (26.7) 4300 (28.4)  33179 (21.4) 1391 (23.9) 
 
4th quintile 1491 (19.5) 2358 (15.6)  33455 (21.6) 1120 (19.2) 
 
5th quintile (highest) 1152 (15.1) 1101 (7.3)  43538 (28.1) 735 (12.6) 
  Unknown 4 (0.1) 2 (0.0)  25 (0.0) 0 (0.0) 
Initial antenatal attendance        
  1-12 weeks 4429 (58.0) 8717 (57.6)  103712 (67.0) 3241 (55.6) 
  13-25 weeks 2742 (35.9) 5261 (34.8)  45663 (29.5) 2212 (37.9) 
  ≥26 weeks 390 (5.1) 971 (6.4)  4626 (3.0) 311 (5.3) 
  Unknown 71 (0.9) 180 (1.2)  794 (0.5) 65 (1.1) 
Diabetes mellitus      
 No diabetes 7412 (97.1) 14725 (97.3)  148225 (95.8) 5615 (96.3) 
  Pre-existing diabetes 23 (0.3) 52 (0.3)  496 (0.3) 18 (0.3) 
  Gestational diabetes 197 (2.6) 352 (2.3)  6074 (3.9) 196 (3.4) 
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(continued)      
Hypertensive disorders      
 No hypertension 6797 (89.1) 13890 (91.8)  136014 (87.9) 5188 (89.0) 
 Pre-existing hypertension 74 (1.0) 99 (0.7)  1852 (1.2) 42 (0.7) 
 Gestational hypertension 761 (9.9) 1140 (7.5)  16929 (10.9) 599 (10.3) 
       
Respiratory conditions      
 No 7468 (97.9) 14731 (97.4)  153067 (98.9) 5743 (98.5) 
  Yes 164 (2.1) 398 (2.6)  1728 (1.1) 86 (1.5) 
Mode of delivery        
  Vaginal 4523 (59.3) 10004 (66.1)  80110 (51.8) 3530 (60.6) 
  Instrumental 1256 (16.5) 2041 (13.5)  32798 (21.2) 928 (15.9) 
  Prelabour caesarean 546 (7.2) 902 (6.0)  14279 (9.2) 404 (6.9) 
  Intrapartum caesarean 1305 (17.1) 2171 (14.4)  27513 (17.8) 965 (16.6) 
  Unknown 2 (0.0) 11 (0.1)  95 (0.1) 2 (0.0) 
Postpartum haemorrhage      
 No 7102 (93.1) 14233 (94.1)  143276 (92.6) 5410 (92.8) 
  Yes 530 (6.9) 896 (5.9)  11519 (7.4) 419 (7.2) 
Gestation age       
   ≥37 weeks 7097 (93.0) 13886 (91.8)  146208 (94.5) 5399 (92.6) 
  <37 weeks, medically indicated 184 (2.4) 372 (2.5)  3321 (2.1) 166 (2.8) 
  <37 weeks, spontaneous 350 (4.6) 871 (5.8)  5263 (3.4) 264 (4.5) 
  Unknown 1 (0.0) 0 (0.0)  3 (0.0) 0 (0.0) 
Stillbirth/Live birth      
 Live birth 7554 (99.0) 14995 (99.1)  153839 (99.4) 5780 (99.2) 
  Stillbirth 77 (1.0) 125 (0.8)  898 (0.6) 44 (0.8) 
  Unknown 1 (0.0) 9 (0.1)  58 (0.0) 5 (0.1) 
Apgar 5 minute*      
 <7 157 (2.1) 279 (1.9)  2444 (1.6) 107 (1.9) 
 ≥7 7391 (97.8) 14687 (97.9)  151278 (98.3) 5662 (98.0) 
  Unknown 6 (0.1) 29 (0.2)  117 (0.1) 11 (0.2) 
Birth weight for gestation age*       
  Appropriate 5929 (78.5) 11102 (74.0)  125180 (81.4) 4572 (79.0) 
  Small 1092 (14.5) 3300 (22.0)  15652 (10.2) 757 (13.1) 
  Large 528 (7.0) 584 (3.9)  12854 (8.4) 446 (7.7) 
  Unknown 5 (0.1) 9 (0.1)  153 (0.1) 5 (0.1) 
Special care nursery admission*      
 No 6227 (82.4) 12087 (80.6)  129452 (84.1) 4757 (82.3) 
  Yes 1327 (17.6) 2908 (19.4)  24387 (15.9) 1023 (17.7) 
*: Among live births 
19 
 
Table 2: Factors associated with change in smoking status between pregnancies: adjusted odds ratio 
(OR), and 95% confidence interval (95%CI) 
 
 
Quitting smoking by second 
pregnancy among smokers 
during first pregnancy 
 
Smoking during second 
pregnancy among non-smokers 
during first pregnancy 
% OR (95%CI)* 
 
% OR (95%CI)* 
Year of first delivery      
 2000 31.6 1.0 
 
4.7 1.0 
 2001 33.7 1.08 (0.95-1.24) 
 
4.5 0.98 (0.87-1.10) 
 2002 33.5 1.09 (0.96-1.24) 
 
3.8 0.85 (0.75-0.96) 
 
2003 33.2 1.11 (0.97-1.27) 
 
3.5 0.80 (0.71-0.90) 
 
2004 33.3 1.13 (0.98-1.29) 
 
3.4 0.77 (0.68-0.88) 
 
2005 33.9 1.21 (1.06-1.39) 
 
3.4 0.84 (0.74-0.95) 
 
2006 34.9 1.28 (1.11-1.48) 
 
3.2 0.80 (0.70-0.91) 
 
2007 34.1 1.30 (1.12-1.51) 
 
3.6 1.00 (0.88-1.13) 
 
2008 34.0 1.42 (1.20-1.68) 
 
2.9 0.83 (0.72-0.97) 
 
2009 30.2 1.37 (1.07-1.75) 
 
3.2 0.77 (0.61-0.99) 
Birth interval      
 <2 years 29.3 1.0 
 
3.3 1.0 
 2-2.9 years 35.3 1.25 (1.16-1.35) 
 
3.1 1.01 (0.95-1.08) 
 
≥3 years 37.0 1.51 (1.40-1.62) 
 
4.9 1.34 (1.25-1.43) 
Maternal age      
 Under 20 years 21.9 1.0 
 
16.5 1.0 
 20-24 years 30.4 1.28 (1.19-1.39) 
 
6.2 0.51 (0.47-0.56) 
 
25-29 years 41.7 1.67 (1.52-1.83) 
 
2.5 0.30 (0.27-0.33) 
 
30-34 years 48.6 1.85 (1.66-2.06) 
 
1.8 0.26 (0.23-0.29) 
 
≥35 years 49.4 1.84 (1.56-2.17) 
 
1.7 0.26 (0.23-0.30) 
Country of birth      
 
English speaking 32.4 1.0 
 
4.1 1.0 
 
Asian 64.9 2.89 (2.27-3.67) 
 
1.4 0.30 (0.27-0.35) 
 
Other non-English speaking 48.0 1.43 (1.24-1.64) 
 
2.8 0.57 (0.51-0.63) 
Marital status      
 
Never married 26.3 1.0 
 
10.7 1.0 
 
Widow, separated, others 28.9 0.92 (0.75-1.13) 
 
4.9 0.73 (0.60-0.89) 
 
Married, de-facto 40.9 1.35 (1.27-1.44) 
 
2.5 0.53 (0.49-0.56) 
Private/public obstetric care      
 
Public 31.0 1.0 
 
5.1 1.0 
 
Private 58.8 1.91 (1.72-2.11) 
 
1.4 0.50 (0.46-0.55) 
Remoteness      
 Rural area 28.5 1.0  4.6 1.0 
 
Urban area 38.3 1.21 (1.14-1.29) 
 
3.2 1.19 (1.12-1.27) 
Socio-economic status      
 
1st quintile (lowest) 28.4 1.0 
 
5.7 1.0 
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 2nd quintile 28.8 1.00 (0.92-1.10) 
 
5.3 0.95 (0.87-1.03) 
 (continued)      
 
3rd quintile 32.2 1.11 (1.02-1.21) 
 
4.0 0.82 (0.76-0.89) 
 
4th quintile 38.7 1.26 (1.15-1.39) 
 
3.2 0.83 (0.76-0.90) 
 
5th quintile (highest) 51.1 1.63 (1.46-1.82) 
 
1.7 0.55 (0.50-0.61) 
Initial antenatal attendance      
 1-12 weeks 33.7 1.0   3.0 1.0 
 13-25 weeks 34.3 1.09 (1.02-1.16)   4.6 1.21 (1.14-1.28) 
 ≥26 weeks 28.7 1.01 (0.88-1.15)   6.3 1.30 (1.14-1.48) 
Diabetes mellitus      
 
No diabetes 33.5 1.0   3.6 1.0 
 
Pre-existing diabetes 30.7 0.74 (0.44-1.24)   3.5 1.09 (0.68-1.71) 
  Gestational diabetes 35.9 0.83 (0.69-1.00)   3.1 1.25 (1.07-1.45) 
Hypertensive disorders      
 
No hypertension 32.9 1.0  3.7 1.0 
 Pre-existing hypertension 42.8 1.28 (0.93-1.76)  2.2 0.61 (0.45-0.83) 
 Gestational hypertension 40.0 1.36 (1.23-1.51)  3.4 0.81 (0.74-0.89) 
Respiratory disorders      
 
No 33.6 1.0  3.6 1.0 
 Yes 29.2 0.92 (0.76-1.11)   4.7 0.90 (0.72-1.13) 
Mode of delivery      
 
Vaginal 31.1 1.0   4.2 1.0 
 
Instrumental 38.1 1.08 (1.00-1.18)   2.8 0.97 (0.90-1.05) 
  Prelabour caesarean 37.7 0.93 (0.82-1.05)   2.8 1.13 (1.01-1.26) 
  Intrapartum caesarean 37.5 1.09 (1.01-1.18)   3.4 1.14 (1.06-1.23) 
Postpartum haemorrhage      
 
No 33.3 1.0  3.6 1.0 
 Yes 37.2 1.13 (1.01-1.27)  3.5 0.90 (0.81-1.00) 
Gestational age       
 
≥37 weeks 33.8 1.0  3.6 1.0 
  <37 weeks, medically indicated 33.1 0.85 (0.70-1.03)  4.8 1.49 (1.26-1.77) 
 <37 weeks, spontaneous 28.7 0.90 (0.79-1.03)  4.8 1.25 (1.10-1.43) 
Stillbirth       
 No 33.5 1.0  3.6 1.0 
 Yes 38.1 1.44 (1.06-1.94)   4.7 1.28 (0.93-1.76) 
Apgar 5minute *      
 ≥7 33.5 1.0  3.6 1.0 
 <7 36.0 1.16 (0.94-1.42)  4.2 1.05 (0.86-1.28) 
Birth weight for gestational age      
 
Appropriate 34.8 1.0   3.5 1.0 
 Small 24.9 0.65 (0.60-0.70)   4.6 1.37 (1.26-1.48) 
 Large 47.5 1.66 (1.46-1.89)   3.4 0.91 (0.83-1.01) 
Special care nursery admission*      
 No 34.0 1.0  3.5 1.0 
 
Yes 31.3 0.87 (0.81-0.94)   4.0 1.14 (1.06-1.23) 
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*: Among live births 
**: Adjusted for maternal age, country of birth, Indigenous status, marital status, private obstetric care, SES, 
remoteness, diabetes, hypertension, antenatal attendance, year of delivery, and birth interval. 
 
 
